Bayer to Spend $1 Billion on US Drug R&D

Bayer to Spend $1 Billion on US Drug R&D

The German group has increased the number of US employees working in pharmaceutical marketing by around 50% over the past three years and wants to expand that by a further 75% up to 2030, US pharma chief Sebastian Guth said in an interview with Reuters. Even before...